CD19 CAR T-cell infusion during severe COVID-19 acute respiratory distress syndrome in large B-cell lymphoma
Ann Hematol
.
2023 Jan;102(1):231-234.
doi: 10.1007/s00277-022-05029-w.
Epub 2022 Nov 18.
Authors
Nina Buchtele
1
2
,
Philipp Wohlfarth
2
3
,
Thomas Staudinger
1
2
,
Peter Schellongowski
1
2
,
Ludwig Traby
4
,
Matthias Vossen
4
,
Hanna Knaus
3
,
Elisabeth Lobmeyr
3
,
Werner Rabitsch
3
,
Nina Worel
5
,
Philipp B Staber
6
Affiliations
1
Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria.
2
Intensive Care in Hematologic and Oncologic Patients (iCHOP), Medical University of Vienna, Vienna, Austria.
3
Department of Medicine I, Stem Cell Transplantation Unit, Medical University of Vienna, Vienna, Austria.
4
Department of Medicine I, Division of Infectious Diseases, Medical University of Vienna, Vienna, Austria.
5
Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
6
Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
[email protected]
.
PMID:
36399193
PMCID:
PMC9672583
DOI:
10.1007/s00277-022-05029-w
No abstract available
Publication types
Letter
MeSH terms
Antigens, CD19
COVID-19*
Humans
Immunotherapy, Adoptive
Lymphoma, Large B-Cell, Diffuse* / complications
Lymphoma, Large B-Cell, Diffuse* / therapy
T-Lymphocytes
Substances
Antigens, CD19